Results 171 to 180 of about 9,393,374 (330)
Nucleation‐Controlled Reconstruction of CuOx for Selective CO2 Electroreduction
The ratio of oxygen vacancies (Ov) and exposed Cu2O (111)/(200) of CuOx precatalyst is modulated by nucleation control of Cu(OH)2 precursor. Low Ov ratio and high ratio of Cu2O (111)/(200) in slow‐nucleated CuOx reconstructs to high‐coordinated oxide‐derived copper (OD‐Cu) during electrochemical CO2 reduction reaction (CO2RR) and exhibits enhanced ...
Ying Ying Ch'ng +14 more
wiley +1 more source
Resveratrol-embedded hollow cerium oxide nanomedicine targeted treat inflammatory bowel disease through ROS clearance, intestinal mucosal immune homeostasis recovery and gut microbiota modulation. [PDF]
Wang T +9 more
europepmc +1 more source
Our study showed that human primary gingival fibroblast–derived microvesicles on nano‐engineered titanium implants promote early osseointegration and soft‐tissue attachment in vivo. ABSTRACT Titanium dental implants require both reliable osseointegration and peri‐implant soft tissue seal formation to ensure long‐term success. While osseointegration has
Pingping Han +10 more
wiley +1 more source
Impact of bile salts, biopolymer coatings, and food matrix on bilosome-mediated delivery of trans-resveratrol. [PDF]
Can A, Niaz T, Tyler AII, Mackie AR.
europepmc +1 more source
A Synovium‐on‐Chip Platform to Study Multicellular Interactions in Arthritis
The Synovium‐on‐Chip comprises a thin microporous PDMS membrane to support co‐culture of fibroblast‐like synoviocytes (FLS), THP‐1‐derived macrophages, and endothelial cells, enabling real‐time analysis of synovial‐vascular interactions. FLS migration through the pores drives endothelial remodeling, while TNF‐α stimulation induces robust inflammatory ...
Laurens R. Spoelstra +8 more
wiley +1 more source
Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3 axis: From computational analysis to experimental validation. [PDF]
Feng C +5 more
europepmc +1 more source
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang +13 more
wiley +1 more source

